noscript

News and Announcements

Anteo Diagnostics Ltd Signs Patent And Technology License Agreement With eBioscience

  • Published March 13, 2012 12:10AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Anteo Diagnostics Ltd announced that it has signed a Patent and Technology License Agreement with eBioscience, life sciences company, providing them with access to the Company’s Mix&Go technology. Under the terms of the agreement, Anteo will supply Mix&Go for use in the manufacture of biological reagents for all applicable markets in which the Company operates. Anteo will receive an initial upfront payment, fixed revenue for Mix&Go reagent supplied, and a royalty fee paid quarterly based on a percentage of worldwide net sales. eBioscience has undertaken technical assessment of the Mix&Go technology, performed due diligence and reached an agreement with great efficiency. The outcome could only occur with goodwill from both parties. Further, Anteo expects to be working in close collaboration with eBioscience into the future to ensure that all products that incorporate Mix&Go are delivered to the market promptly, that the technology is used across the eBioscience product range and that where applicable, Mix&Go is used in new products.

—–

To view the full article, please click here.

 

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now